Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

NAFLD Clinical Trials

11 recruiting trials for NAFLD. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
11
Total Trials
11
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT06413069

Effects of Almonds in Glucose-intolerant Adults (AGAMEMNON)

Tree nuts - such as almonds - contribute to beneficial effects of the Mediterranean diet on risk for cardiovascular events, type 2 diabetes, dyslipidemia, hypertension,...

Sponsor: Charite University, Berlin, GermanyEnrolling: 1501 location
RECRUITINGNCT06671886

NAFLD Clinical Care Pathway

Non-alcoholic fatty liver disease (NAFLD) is a new condition that has become the most common chronic liver disease in the world and a main cause of liver cirrhosis, liver failure...

Sponsor: VA Office of Research and DevelopmentEnrolling: 321 location
RECRUITINGPhase 2NCT05424003

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

In this study, semaglutide will be compared to placebo (a look-alike inactive substance, a "sugar pill") to determine if its use will prevent weight gain after liver...

Sponsor: Virginia Commonwealth UniversityEnrolling: 501 location
RECRUITINGNCT06888310

Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is responsible for a significant proportion of liver-related deaths and healthcare costs in the United States, accounting for...

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCSEnrolling: 4081 location
RECRUITINGNCT05816915

Lifestyle Modification in the Treatment of NAFLD.

The project will study the impact of individually tailored lifestyle counselling compared to standard care on the parameters of NAFLD/NASH in patients with metabolic syndrome. The...

Sponsor: General University Hospital, PragueEnrolling: 1001 location
RECRUITINGNCT06275906

Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.

The study in question is an interventional study with nutritional intervention. The aim of the study is to evaluate whether the adoption of two different models of Mediterranean...

Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de BellisEnrolling: 601 location
RECRUITINGNCT06814600

Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients

Non-alcoholic Fatty Liver Disease (NAFLD) refers to a spectrum of disease characterized by the presence of more than 5% of steatosis in hepatocytes of individuals who consume...

Sponsor: Centre Hospitalier Universitaire Saint PierreEnrolling: 1501 location
RECRUITINGNCT06396871

Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases

The goal of this cross-sectional observational study is to to perform a thorough characterization of the quantitative and qualitative differences in peripheral blood cells, and...

Sponsor: Technische Universität DresdenEnrolling: 1801 location
RECRUITINGNCT05477212

Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet.

This study is open label, with one arm only. In this study will be enrolled patients with obesity (BMI more than 30). Aim of the study is to determine the influence (if any) of a...

Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de BellisEnrolling: 301 location
RECRUITINGNCT05930093

Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects

Non-alcoholic fatty liver disease (also called NAFLD) is a disease in which excessive fat accumulates in the liver of a patient without a history of alcohol abuse. Early-stage...

Sponsor: TCM Biotech International Corp.Enrolling: 1081 location
RECRUITINGNCT06098417

Biomarkers in the Diagnosis and Prognosis of NAFLD

Fibrosis is considered the leading cause of liver diseases and related mortality. Specifically, hepatic fibrosis is regarded as the consequence of reparative mechanisms initiated...

Sponsor: University of TriesteEnrolling: 5001 location